Literature DB >> 8123502

Soluble IL-2 alpha and ovarian cancer.

D P Barton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8123502      PMCID： PMC1968877          DOI： 10.1038/bjc.1994.117

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  The third molecule associated with interleukin 2 receptor alpha and beta chain.

Authors:  M Kamio; N Arima; M Tsudo; K Imada; M Ohkuma; T Uchiyama
Journal:  Biochem Biophys Res Commun       Date:  1992-05-15       Impact factor: 3.575

Review 2.  The IL-2/IL-2 receptor system: a current overview.

Authors:  T Taniguchi; Y Minami
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

3.  Cloning of the gamma chain of the human IL-2 receptor.

Authors:  T Takeshita; H Asao; K Ohtani; N Ishii; S Kumaki; N Tanaka; H Munakata; M Nakamura; K Sugamura
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

4.  High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer.

Authors:  D P Barton; D K Blanchard; B Michelini-Norris; S V Nicosia; D Cavanagh; J Y Djeu
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

5.  Interleukin-2 receptor and ovarian cancer.

Authors:  O J Owens; C Taggart; R Wilson; J J Walker; J H McKillop; J H Kennedy
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.